[Multifocal epithelioid haemangioendothelioma]

Tunis Med. 2009 Sep;87(9):637.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Bone Neoplasms* / diagnostic imaging
  • Bone Neoplasms* / drug therapy
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Fatal Outcome
  • Female
  • Hemangioendothelioma, Epithelioid* / diagnosis
  • Hemangioendothelioma, Epithelioid* / diagnostic imaging
  • Hemangioendothelioma, Epithelioid* / drug therapy
  • Hemangioendothelioma, Epithelioid* / pathology
  • Humans
  • Liver / pathology
  • Liver Neoplasms* / diagnosis
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology
  • Lung / pathology
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / diagnostic imaging
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Middle Aged
  • Neoplasms, Multiple Primary* / diagnosis
  • Neoplasms, Multiple Primary* / diagnostic imaging
  • Neoplasms, Multiple Primary* / drug therapy
  • Neoplasms, Multiple Primary* / pathology
  • Radiography, Abdominal
  • Radiography, Thoracic
  • Radionuclide Imaging
  • Time Factors
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide